Kaiser Permanente Ventures and Samsung Next invested in the digital mental health treatment developer through a series B round that will fund product development and commercialisation.

US-based mental health treatment developer Big Health has secured $39m in a series B round featuring Kaiser Permanente Ventures and Samsung Next, subsidiaries of healthcare provider Kaiser Permanente Ventures and electronics producer Samsung. Healthcare investment firm Gilde Healthcare and venture capital firm Morningside Ventures co-led the round, which included VC firm Octopus Ventures. Janke Dittmer,…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.